4.2 Review

Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

Amit V. Khera et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Hematology

Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I

Estelle Nobecourt et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)

Article Hematology

Role of 3β-Hydroxysteroid-Δ24 Reductase in Mediating Antiinflammatory Effects of High-Density Lipoproteins in Endothelial Cells

K. C. Y. McGrath et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)

Article Medicine, General & Internal

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

The Emerging Risk Factors Collaboration*

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Endocrinology & Metabolism

Oxidative stress as a major culprit in kidney disease in diabetes

Josephine M. Forbes et al.

DIABETES (2008)

Review Cardiac & Cardiovascular Systems

Endothelial and antithrombotic actions of HDL

Chieko Mineo et al.

CIRCULATION RESEARCH (2006)

Article Hematology

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits

SJ Nicholls et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)